Objective: To demonstrate the feasibility and safety of using functional magnetic resonance imaging (fMRI) to determine the blood oxygen level dependent changes (BOLD) in patients undergoing vagal nerve stimulation (VNS) for the treatment of epilepsy.
INTRODUCTION
Vagal nerve stimulation (VNS) is the first FDA approved device to treat medically refractory patients with partial onset seizures. Seizure frequency can be reduced by an average of 30 to 40% 1 . The details of how VNS can reduce seizure frequency is unknown. Attempts at functional imaging have consisted of cerebral blood flow studies (PET and SPECT) that have been performed in a small number of patients with VNS [2] [3] [4] [5] [6] [7] [8] .
Functional magnetic resonance imaging (fMRI) is a noninvasive technique to map various brain functions. Images are a result of detecting local changes in cerebral blood oxygenation presumably as a consequence of neuronal activity. Image acquisition is of the order of milliseconds [9] [10] [11] [12] .
To date, fMRI has not been reportedly utilized to study the effect of VNS upon the central nervous system. This pilot study represents an initial attempt to study the acquisition of fMRI images during intermittent VNS in patients with partial seizures.
METHODS
Four human subjects (named A, B, C, D) with intractable partial seizures and a 6 months history of implanted vagus nerve stimulator (Cyberonics model 100) were asked to give written informed consent to undergo fMRI imaging. The subjects were instructed to remain in a relaxed, motionless resting state 10, 11 for the duration of image acquisition. For each subject, anatomic images were acquired. This was followed by three time-courses of gradientrecalled echo-planar images (EPI). Our priority in this pilot study was to select patients who could provide a high level of cooperation to assure acceptable results. As a result the four subjects were not demographically matched. The patients were considered refractory to medication and had received long term monitoring as part of their presurgical evaluation, but found to have poorly localized seizures. Table 1 depicts the essential patient characteristics. Patient A was a 22-year old man who suffered daily simple partial seizure as well as complex partial seizures twice per week. He was scanned 6 months ±2 weeks post-implant. He was on extended release carbamazepine 600 mg bid and 3000 mg QD of valproic acid in divided dosages. On follow-up at 2 years post-VNS implant (with a setting of 1.8 min off and 30 seconds on at 2 mA) he no longer suffered from simple seizures but still had weekly complex partial events and oxcarbazepine was added.
Patient B was a 49-year old man who prior to implant suffered 3-4 simple seizures per day and was scanned 6 months ±2 weeks post-implant. He was taking 900 mg daily of carbamazepine and 550 mg of topiramate daily. 21 months post-implant (setting of 5 minutes off and 30 seconds on at 2.0 mA) the patient has had only rare seizures on a reduced amount of medication. The reduction of dosage did not affect seizure frequency.
Patient C was a 27-year old man who suffered 6-7 complex partial seizures per month and was scanned 7 months post-implant. He was taking divided doses of 1200 mg QD carbamazepine, 750 mg daily of valproic acid, 625 mg daily of mysoline and 600 mg daily of topiramate. At 18 month post-implant (setting of 5 minutes off and 30 seconds on at 2.25 mA) he suffered one seizure per week but the number of medications was reduced to one (valproic acid).
Patient D was a 28 year old woman who suffered one secondarily generalized tonic-clonic seizure per week and was scanned 6 months ±2 weeks postimplant. She was on lamotrigine 250 mg daily and topiramate 50 mg daily. At one-year follow-up (setting of 5 minutes off and 30 seconds on at 1.5 mA) the patient felt no change in seizure frequency and eventually requested the device to be turned off. All devices were set at a frequency of 30 Hz and pulse width of 500 microseconds. The device that had been implanted was oriented as shown in Fig. 1(a) . In this way, the static magnetic field Bo has no significant effect on the reed switch in the device while the patient is in the scanner. This is because the reed switch is now oriented parallel to the static magnetic field, the direction of which is shown in Fig. 1(a) . Although positioning the device exactly as shown in our figure assures precise parallel orientation of the reed switch, it has been demonstrated 13 that provided that the device is oriented so that the electrode inputs are parallel to the long axis of the patient, the device should operate during MRI scanning. This suggests that exact parallel orientation of the reed switch is not imperative. Hence, any slight pendular shifting of the device about the sutured down contact may not affect fMRI-scanning ability. Moreover, verification of positioning can be done via chest x-ray prior to fMRI scanning if necessary. However, this orientation of the device will not prevent stimulation being inhibited while the patient is near the scanner. The suggested orientation, unlike any other positioning, only assures that once the patient is actually in the scanner, parallel to the magnetic field, the device will resume cycling. This can be verified once the patient reports feeling the device cycle on and off. Verification that the device was operating during scanning can also be done by checking the device history. First note the total 'on' time before scanning and then after scanning. Then subtract the times and compare with the duration the patient was in the scanner as well as when the patient reported the 'on' cycle. We evaluated the model 100 and not the newer model 101. The reed switch on model 101 is located differently in the device. See Fig. 1(b) . However, in this case, if the device is oriented as Maniker 13 suggests for model 100, with the input leads oriented parallel to the long axis of the patient, the switch is exactly parallel.
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Reed Switch Only the head coil was used and this avoided the possibility of wire heating in the implanted device that can occur with a body transmit coil 14 . IRB approval was obtained because the output current was not programmed to 0 mA when the patient was being scanned, as recommended in the physician manual 15 . During the scan the programmed stimulation was 0.25 mA less than that usually programmed for each patient. The reason for choosing this setting was mainly for tolerance purposes. Despite the lowering of their settings, patients were still reporting feeling the stimulation.
The imaging platform was a 1.5 T clinical imager (Sigma, General Electric Medical Systems, Waukesha, WI) specially equipped with a home-built balanced torque, three-axis gradient coil, and shielded endcapped quadrature transmit/receive coil [16] [17] [18] . Highresolution anatomic images were obtained in sagittal projections with the spoiled GRASS pulse sequence, with TR = 600 ms, TE = 10 ms, FOV = 24 cm, and matrix size = 256 × 256. On the basis of these images, 12 slices covering the entire brain were used for functional imaging. For each resting acquisition, a time course of images, consisting of 30 seconds 'on' and 30 seconds 'off' for 6 minutes, was obtained with gradient-recalled EPI: 40 ms. TE, 24 cm FOV, 64 × 64 matrix, and 8 mm slice thickness. Since the patients could feel stimulation commence and report it, the cycling of the device could be determined. Other imaging parameters consisted of TR = 2000 ms (flip angle [FA] = 87 • ). The signal intensity was plotted as a function of time for each pixel, resulting in 64 × 64 matrix/8 mm cut thickness yielding voxels with dimensions of 3.75 × 3.75 × 8 mm. During reconstruction of images, Bo field maps were used to reduce field inhomogenieties.
All data were analyzed for the presence of motioninduced artifacts. While many algorithms exist for the detection and correction of misregistered images, a contour-based cross-correlation algorithm was used for detecting the presence of head motion 19, 20 . A contour image of the first image in each data set was used as a reference and the motion estimated for every other image in the data set. The estimated motion was tabulated as a function of time for each subject and for each data set. Data sets that exhibited head motion were corrected prior to further analysis. After motion correction, if an image set still exhibited head motion of more than one pixel, the image set was discarded.
A representative time-course from each subject was used as a reference waveform and cross-correlated with every pixel in the image on a pixel-by-pixel basis. Cross-correlation assumes that neuronal activity and the fMRI signal change coherently with the stimulus paradigm. For the paradigm used in this study, this assumption seems reasonable. Using an ideal reference waveform, cross-correlation analysis identifies pixels that have a shape that is similar to the reference waveform. Only pixels with a correlationcoefficient greater than 0.35 were considered as this assured a statistical significance of P< 0.01. Moreover, selection of this correlation-coefficient threshold yields the given p value and represents the statistical significance for acceptance of signals not due to chance 21, 22 .
RESULTS
During the stimulation phase, signal intensity from different regions of the brain varied by about 5% above the baseline. During the no-stimulation phase acquisitions, the signal intensity varied by about 1% of baseline. By inspection, it was seen in a number of pixels that signal intensity changed synchronously with the on:off cycle of the VNS. Fourier analysis performed on time-course plots indicated a dominant low-frequency component present on these pixels. It has been demonstrated that the VNS 'on' state does not distort or interfere with images 23 . Similarly, we did not find this to be the case with our imaging results. Tables 2 and 3 show the tally of activated pixels per region and side of each patient. It also shows tabulated totals by region for all patients. The images shown in Fig. 2 are selected images representatives of the 12 sagittal slices obtained for each patient. Pixels in yellow, orange, and red indicated the most significant change. Moreover at our institution (MCW) the yellow, orange, and red pixels were set to signify a correlation greater than 0.55 (P< 0.001), 0.45 (P< 0.005) and 0.35 (P< 0.01) respectively. However, color-coding can be adjusted according to preference 22 . Tables 2 and 3 : Tabulated number of pixels activated in various brain areas by patient, A-D. Pixels that were red, orange or yellow were manually counted. Overall, there were four subregions of brain showing consistent and robust activation in each of the individuals studied. These include the left superior temporal gyrus, the inferior frontal gyrus bilaterally, medial portions of the superior frontal gyrus bilaterally in the region of supplementary motor cortex, and the posterior aspect of the middle frontal gyrus bilaterally. The other areas showed variable and less robust activity.
DISCUSSION
fMRI identified areas of blood flow alteration with left vagus nerve stimulation in refractory partial onset seizure patients. These changes were predominantly seen in bi-frontal and parietal structures. This is not surprising given the known widespread anatomic pathways of the vagus nerve.
The results show obvious variation between subjects. No correlation was found between the activated regions, stimulation parameters and seizure frequency reduction. We however, did not expect this due to the small sample size. On the other hand, our method of data analysis did not allow for detection of the possible decreased areas of neuronal activation.
The widespread and variable activation seen in our four subjects may be influenced by a variety of factors, including statistical variance associated with a small study population, uncontrolled cognitive processes, and uncontrolled responses to vagal nerve stimulation. The response of the subjects to the perception generated by vagal nerve stimulation and inherent variability of the responses among subjects is unknown, but may have accounted for the variability in activation seen within specific subregions of brain. For example, subject A showed much greater activity in the left superior temporal and supplementary motor areas, than the other three subjects. Whether this is simply due to statistical variance or is a genuine response to vagal nerve stimulation is not clear at this point. On the other hand, the robust and consistent activation of certain subregions of brain is of unknown significance. Future studies are required to confirm the predominant activity seen and help understand the significance of this finding.
It is difficult to make fruitful comparisons between our fMRI results and those seen with PET or SPECT studies. The methods and patients differed considerably among all these studies. Garnett et al. 2 found regional cerebral blood flow changes (rCBF) in the left anterior cingulate gyrus among the five patients they studied. However, two of the patients had 'electrical evidence of seizure activity' during the study. Details of the stimulation parameters and duration of implant were not mentioned. Ko et al. 3 found increased rCBF in the contralateral thalamus, posterior temporal cortex, left putamen and inferior cerebellum in three patients they studied. Two of the patients had epilepsy surgery prior to VNS implant. The three patients had at least 2 months of VNS prior to being scanned. A second study by Ko 4 with nine patients found a correlation with reduction in seizure frequency and decreased rCBF in the right fusiform gyrus. Henry et al. 5 studied 10 patients within 24 hours of VNS implant. As such, the intensity of stimulation in their 'high-stimulation' group was considerably lower than that seen with patients who have had VNS for a longer duration. Nevertheless, they found significant changes in rCBF in dorsal medulla, right sensory cortex, bilateral thalamus, cerebellum and multiple limbic structures. Henry 6 , in a second study using 11 patients, found a correlation with decreased seizure frequency and rCBF changes in the thalamus. Vonck et al. 7 noted a significant rCBF change (decrease) in the left thalamus with stimulation. The changes in rCBF found in these five studies are consistent with the known anatomic pathways of the vagus nerve 8 .
Our study found little activation in the brainstem, thalamus, and basal ganglia The relative lack of activity seen in these deeper structures may be due to the lower concentration of microvasculature causing a less BOLD signal compared to that seen with cortical activation. This could also be due to the function of our scanning and analysis methods. Another more refined protocol will help explore brainstem involvement. Moreover, our intention in this pilot study was to establish safety and feasibility of using fMRI to evaluate VNS effects. We acknowledge that our results in general are not ready to stand up to vigorous comparisons with established PET imaging.
We make the assumption that the changes noted on fMRI are a result of neuronal activity caused by VNS. Whether VNS causes any direct microvascular changes apart from neuronal influence is not clear. Validation of our assumption is expected once individual patients have both fMRI and either PET or SPECT scans.
Our patients had seizures that were poorly localized on prior monitoring. What effects fMRI can detect in primary generalized epilepsy patients with VNS remain to be seen. A study with a larger number of patients may be able to demonstrate differences between patients that have had varying success with their device. Additional studies may also allow comparison of different stimulator settings. Possibly, manual stimulation of the left side of the neck could be compared with VNS. This might help clarify if the changes seen are a result of local sensory stimulation or due to vagus nerve pathway stimulation.
No complications of VNS were noted in any of the four patients studied. The patients denied any discomfort during the study. After scanning, the devices were re-interrogated. The study parameter settings were unaltered; verifying that scanning did not change the programmed parameters. The patient's
